Examining the secretor status in the saliva of patients with oral pre-cancerous lesions

被引:15
作者
Vidas, I
Delajlija, M
Temmer-Vuksan, B
Stipetic-Mravak, M
Cindric, N
Maricic, D
机构
[1] Univ Rijeka, Fac Med, Dept Stomatol, HR-51000 Rijeka, Croatia
[2] Croatian Inst Transfus, Zagreb, Croatia
[3] Univ Zagreb, Fac Stomatol, Dept Oral Pathol, Zagreb 41000, Croatia
关键词
D O I
10.1046/j.1365-2842.1999.00314.x
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
It has been demonstrated in a number of earlier studies on the aetiology and pathogenesis of certain diseases that the patients' secretor status (ABO (H) blood group antigens) may possibly be a factor influencing the development of systemic oral diseases, This likelihood has prompted the present study, to examine the differences in the saliva secretor status by comparing patients with oral precancerous lesions on the one hand, and the healthy population on the other; (i) in relation to the intensity of the clinical manifestation of diseases and (ii) in relation to the intensity of epithelial dysplasia of patients with oral pre-cancerous lesions. In total 122 subjects were examined, half of whom suffered from oral pre-cancerous lesions (excluding Candida albicans in oral smears), while the other half were the healthy control group. All were subjected to clinical oral examinations and standard evaluation tests in order to establish the secretor status of their saliva. In the group of patients with oral precancerous lesions (experimental group), a pathohistological examination of the oral mucosa was performed. The results have demonstrated that the large majority of the people examined in both groups were secretors and no significant difference between secretors and non-secretors was found in the comparison between the experimental group and the healthy control group. However, (i) we found a higher intensity of oral disease in the non-secretor group, and (ii) the occurrence of epithelial dysplasia was found exclusively in the non-secretor group.
引用
收藏
页码:177 / 182
页数:6
相关论文
共 21 条
  • [1] ABBOUD RT, 1982, AM REV RESPIR DIS, V126, P1089
  • [2] BLACKWELL CC, 1986, PROTEIN CARBOHYDRATE, P231
  • [3] BLACKWELL CC, 1986, LANCET, V335, P687
  • [4] BURFORDMASON AP, 1988, J MED VET MYCOL, V26, P49
  • [5] SECRETION OF BLOOD GROUP ANTIGENS AND PEPTIC ULCER
    CLARKE, CA
    EVANS, DAP
    MCCONNELL, RB
    SHEPPARD, PM
    [J]. BRITISH MEDICAL JOURNAL, 1959, 1 (MAR7) : 603 - 607
  • [6] COHEN BH, 1975, J HOPKINS MED J, V104, P137
  • [7] DABELSTEEN E, 1988, Proceedings of the Finnish Dental Society, V84, P19
  • [8] FOSTER MT, 1976, J INFECT DIS, V151, P133
  • [9] RELATIONSHIPS OF THE SOLUBLE HUMAN A-ANTIGEN, B-ANTIGEN, AND H-ANTIGEN OF BLOOD GROUP-A1B INDIVIDUALS
    GRUNDBACHER, FJ
    [J]. EXPERIENTIA, 1987, 43 (06): : 616 - 617
  • [10] HIGGINS ITT, 1963, BRIT J IND MED, V20, P324